Om

HYTN Innovations Inc. is a Canadian pharmaceutical and healthcare company specializing in products containing psychoactive and psychotropic compounds, with a primary focus on cannabis-derived cannabinoids. The company formulates, manufactures, markets, and sells premium cannabis goods, including edible cannabis, cannabis-infused beverages, nano-shot formats, and cannabis flower, serving both medical and adult-use markets. HYTN Innovations Inc. operates as a Good Manufacturing Practice (GMP) processor and active pharmaceutical ingredient (API) fabricator, supplying pharmaceutical-grade cannabinoid medicines and ingredients to regulated markets such as Canada, Australia, the United Kingdom, and Germany. It also maintains capabilities for GMP psilocybin mushroom manufacturing and other restricted input materials for domestic and international partners. Headquartered in Kelowna, British Columbia, the company plays a niche role at the intersection of life sciences, pharmaceuticals, and cannabis consumer packaged goods by combining high regulatory standards with scalable manufacturing for global, federally regulated channels.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I HYTN INNOVATIONS MED ENDAVU: Køb HYTN Innovations ($HYTN) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i HYTN Innovations, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.